Search results
US FDA grants accelerated approval to Genfit and Ipsen's liver disease drug
Reuters· 3 days agoThe U.S. Food and Drug Administration has granted accelerated approval French drugmakers Ipsen and...
Zealand Pharma Shares Jump After Drug Shows Promise in Liver Trial
Market Watch· 7 days agoZealand Pharma shares rose after a drug candidate being tested as a treatment for obesity showed positive results in a mid-stage clinical trial for a type of fatty liver disease. At 1544 GMT ...
Dr. Oz discusses how to stop overeating
NJ.com· 1 day agoOvereating happens because of an unchecked impulse to eat and a lack of being able to feel satiated. One reason may be that you aren’t getting the...
High levels of novel biomarker GDF15 in steatotic liver patients linked to increased liver cancer...
Medical Xpress· 7 days agoThe findings are published in the journal Alimentary Pharmacology & Therapeutics. Steatotic (fatty) liver disease is on the rise in many countries around the world. A rise in steatotic liver ...
US FDA grants accelerated approval to Genfit and Ipsen’s liver disease drug
WHTC 1450 Holland· 3 days ago(Reuters) -The U.S. Food and Drug Administration has granted accelerated approval French drugmakers...
The 10 health benefits of giving up alcohol
The Telegraph via Yahoo News· 1 day agoIt’s often said that the British love their tea, discussing the weather and, let’s face it, enjoying a tipple. Little wonder, then, that research from...
Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL...
The Herald Journal· 3 days agoLipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company, today announced that Phase 2 results on LPCN 1148 in cirrhosis were featured in a late breaking oral presentation at the European Association ...
Europe Needs Chinese Investment | by Dalia Marin - Project Syndicate
Project Syndicate· 7 hours agoOver the past two decades, the productivity gap between Europe and the United States has steadily...
Surrozen reports positive Phase 1a trial results for liver therapy By Investing.com
Investing.com· 3 days agoThe study, which involved healthy volunteers and patients with a history of liver cirrhosis, was...
GSK acquires Elsie to unlock oligonucleotide therapeutics
Pharmaceutical Technology via Yahoo Finance· 6 days agoGSK has acquired Elsie Biotechnologies for $50m to unlock the potential of oligonucleotide...
